Just one-third of those with hepatitis C seek treatment. Pa. has a plan, but barriers remain
“While hepatitis C is curable, treatments as simple as a course of medication are not reaching the majority of people who need them, a recent report from the U.S. Centers for Disease Control and Prevention found. Inaccessibility to treatment is an issue in Allegheny County as well, with local experts pointing to growing rates of the infection.”
Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients
“Conclusions: Based on the high prevalence of HCV, mental health inpatients should be included in groups for whom universal screening is recommended. Since on-site treatment was more successful than referral to external hepatology specialists, utilizing inpatient admission as an opportunity for HCV screening and treatment should receive more consideration.”
Survey shows only 68% of people with hepatitis C aware of the infection
“Key takeaways: More than 2 million people had current HCV infection, but only 68% were aware of it. Infection rates were higher among older adults, people experiencing poverty and those with public or no insurance.”
Safeguarding mothers and newborns: the urgent need to address hepatitis during pregnancy
““We are not waiting”—Under this central theme, we marked the annual Hepatitis Awareness Day on July 28th. It is crucial to emphasize this statement for the vulnerable populations affected: expectant mothers and newborn babies. They cannot afford to wait for hepatitis screening, treatment, and newborn vaccination. These individuals face unique risks of vertical (mother-to-child) transmission of the virus, which is often overlooked but is a critical issue concerning hepatitis infection during pregnancy.”
Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma
“Hepatocellular carcinoma is a leading cause of cancer-related deaths due to its complexity in diagnosis, chemo-resistance, and aggressive nature. Identifying pathogenic single nucleotide polymorphism (SNP) in protein kinase C iota (PKCι) can be a potential biomarker in the prognosis and treatment of HCC.”
Hepatitis B Elimination Goal May Be Unrealistic for 2030
“Targets for eliminating hepatitis B virus (HBV) globally by 2030 are currently unrealistic for a number of countries impacted by the chronic viral disease. New data from the multinational non-profit Polaris Observatory Collaborators show fewer than 1 in 10 patients eligible for HBV treatment across 170 countries actually received treatment.”
Psychology, Public Health Sciences faculty and Prisma Health lead national study demonstrating hepatitis C cure in people who inject drugs
“Hepatitis C is rampant among people who inject drugs, and a team of Clemson University and Prisma Health researchers led a nationwide study, funded by the Patient-Centered Outcomes Research Institute, that proved the success of two models of treatment to cure the disease.”
People Cured of Hepatitis C Still Face Significant Mortality Risk
“Patients with hepatitis C virus (HCV) achieving cure from successful treatment via interferon-free direct acting antivirals (DAAs) remain at a significantly greater risk of death than the general population, according to new research from the UK.”
Video:
The White House proposes new plan to eliminate hepatitis C
“CBS News chief medical correspondent Dr. Jon LaPook joins “CBS Mornings” with an inside look at a new White House initiative to eliminate hepatitis C in the U.S., a disease that kills thousands of Americans every year despite being curable with treatments.”
